After falling short of analysts' expectations in its latest quarter, Novo Nordisk is restructuring its commercial operations as it looks to fend off challenges to its products. Source: BioSpace
The initial results were presented at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting. Source: BioSpace
Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace
Neurotoxicity killed JCAR015 right along with 5 patients in the lead pivotal study, derailing Juno Therapeutics. Source: BioSpace
Investors in beleaguered Argos are smiling this morning after the company announced some positive interim data for its Phase III kidney cancer drug, Rocapuldencel-T - a trial that some said…
ViGuard Health called on the FDA to declare pyridoxamine to be a dietary supplement and no longer authorized for investigation as a new drug. Source: Drug Industry Daily
The FDA issued a warning letter to Chinese drugmaker Guangdong Zhanjiang Jimin Pharmaceutical following a May inspection of its Guangdong Province facility. Source: Drug Industry Daily
The Federal Circuit upheld two Sanofi patents for its antiarrhythmic drug Multaq (dronedarone) — agreeing with Sanofi’s argument that the drug’s label, which is required to be similar for any…
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended ten medicines for approval, including two orphan medicines and a new treatment for multiple sclerosis. Source: Drug Industry…
Senate Republicans released a competing tax reform plan that — in comparison to the House side’s proposed repeal — merely shrinks the size of the orphan drug research tax credit.…